After Hours Summary: OLED +6.3% on OLED evaluation agreement, MRNA +6.1% after RSV vaccine meets efficacy endpoints, IBKR +2.8%, UAL +1.4% on upbeat Q4 earnings; BGFV -7.7% on lackluster Q4 guidance, OLO -3.7% on COO resigningAfter Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: IBKR +2.8%, UAL +1.4%, UCBI +0.9%
Companies trading higher in after hours in reaction to news: OLED +6.3% (OLED evaluation agreement with Seiko Epson), MRNA +6.1% (RSV vaccine meets efficacy endpoints), CSTL +1.5% (presents at 2023 Winter Clinical Dermatology Conference), TUSK +0.3% (subsidiary puts frac spread into operation), CLB +0.2% (reorganizing corporate structure, redomestication), LOB +0.1% (files mixed shelf)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: BGFV -7.7% (guidance), PRGS -1.9%, AUY -0.2% (Q4 and FY22 production results)
Companies trading lower in after hours in reaction to news: FULC -5.6% ($100 mln public offering), OLO -3.7% (COO to resign), QGEN -1.9% (launches EAZ2 Connect MDx), GH -1.3% (to showcase new data), PBR -0.5% (exceeds its oil and natural gas production target), BLCO -0.2% (acquires AcuFocus), KRP -0.1% (files $125 mln mixed shelf; common units by selling unitholders)
Gapping down
In reaction to earnings/guidance:
- MHK -5.2% (guidance), WHR -3% (completes strategic review; issues guidance), GS -2.3%, TRV -1.5% (guidance)
Other news:
- IQ -7.9% (proposes offering of 76500000 American Depositary Shares each representing seven Class A ordinary shares)
- OMGA -5.5% (to Present Trial-in-Progress Poster for Phase 1/2 MYCHELANGELO I Study)
- PTNR -3.2% (announces receiving a letter from the Ministry of Communications stating it is satisfied that the agreement with BEZEQ)
- RIO -1.7% (reports FY22 production; Pilbara operations increased 1% yr/yr)
- ORLA -1.2% (achieves high end of increased 2022 production guidance and provides 2023 guidance)
- GOLD -1.2% (Q4 Gold Production) .
Analyst comments:
- COLD -2.1% (downgraded to Hold from Buy at Truist)
- KIM -1.6% (downgraded to Hold from Buy at Truist)
- LGF.A -1.6% (downgraded to Hold from Buy at Truist)
- AOS -1.1% (downgraded to Hold from Buy at Loop Capital)
- EXR -1% (downgraded to Hold from Buy at Truist)
- MAA -1% (downgraded to Hold from Buy at Truist)
![]()
Gapping up
In reaction to earnings/guidance:
- DCFC +30.2% (guidance), ADMA +4.7% (guidance), SBNY +4.2%, SI +3%, BOOM +1.8% (CEO steps down; sees Q4 revs above expectations), PAC +0.7%, EDU +0.7%
Other news:
- NATI +15% (Emerson (EMR) submitted a proposal to acquire NI for $53 per share in cash at an implied enterprise value of $7.6 bln)
- IPHA +10.4% (Announces Publication of Preclinical Data with a Trifunctional NK Cell Engager in Acute Myeloid Leukemia in Nature Biotechnology)
- CLLS +7% (Calyxt and Cibus announce the signing of a definitive merger agreement)
- ARBE +5.9% (files for $100 mln mixed securities shelf offering)
- ALKS +5% (Alkermes' nemvaleukin alfa (nemvaleukin) granted an Innovation Passport for the treatment of mucosal melanoma under the Innovative Licensing and Access Pathway by the UK Medicines and Healthcare products Regulatory Agency)
- ARQT +3% (Presents New Phase 2 Long-Term Data Showing Sustained Efficacy and Clearance for a Median of 10 Months with Roflumilast Cream)
- VTNR +2.6% (provides operational update for Q4 2022; Throughput volumes exceeded prior forecast)
- LILM +1.4% (appoints Oliver Vogelgesang as CFO)
- ERJ +1.3% (wins order for 15 new E195-E2 aircraft valued at $1.17 bln)
- CGAU +1.1% (reports Q4 gold production)
- DEO +1% (to acquire Don Papa Rum)
- CLF +1% (increasing current spot market base prices for all carbon hot rolled cold rolled and coated steel products by a minimum of $50 per net ton effective immediately with all new order)
Analyst comments:
- DNB +3% (upgraded to Buy from Neutral at BofA Securities)
- CHD +1.4% (upgraded to Outperform from Neutral at Credit Suisse)
- CDNS +1% (upgraded to Overweight from Neutral at Atlantic Equities)
![]()
Early premarket gappers
- Gapping up:
- IPHA +10.1%, ARBE +5.9%, ARQT +4.8%, SBNY +3.9%, DUOL +3%, STR +2.4%, LILM +1.4%, DEO +1.4%, CGAU +1.1%, ERJ +0.9%, PAC +0.7%
- Gapping down:
- IQ -8.1%, FSM -4.3%, PTNR -3.4%, WHR -3.1%, RIO -2.2%, HDSN -1.1%, LUV -0.8%, EGO -0.7%, SI -0.5%
* Leonardo Raised to Buy at Goldman; PT 11.70 euros
>>> Down
* CA Immo Cut to Hold at Raiffeisen Bank; PT 32.50 euros
>>> Initiation
* Fastenal Rated New Hold at Baptista Research; PT $52.30
>>> Call
* Swatch Raised to Buy at Jefferies on China Consumer Recovery
Macro :
- China’s Better-Than-Expected GDP Fuels Hopes for Rebound
Keep an eye on :
- AIR FP : Arianespace Names Steven Rutgers Chief Commercial Officer